Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BIPOLAR I DISORDER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00363337
What this trial is testing

A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression

Who this might be right for
Bipolar Depression
Lindner Center of HOPE 31
Post-approval studies (Phase 4)Study completedNCT00982020
What this trial is testing

Study in Adolescents With Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar I DisorderSchizophrenia
Eli Lilly and Company 203
Large-scale testing (Phase 3)Study completedNCT01602510
What this trial is testing

Lamotrigine Phase III Study in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
GlaxoSmithKline 265
Not applicableNot Yet RecruitingNCT06882590
What this trial is testing

A Compassionate-focused Intervention for Older People with Bipolar Disorder

Who this might be right for
Bipolar Disorder I or II
University of Manchester 6
Large-scale testing (Phase 3)Study completedNCT06419582
What this trial is testing

BHV-7000 Acute Treatment of Bipolar Mania

Who this might be right for
Bipolar Disorder
Biohaven Therapeutics Ltd. 274
Not applicableStudy completedNCT01828931
What this trial is testing

Lifestyle Intervention for Diabetes and Weight Management in Psychosis

Who this might be right for
Type 2 Diabetes MellitusSchizophreniaSchizoaffective Disorder+5 more
Centre for Addiction and Mental Health 120
Large-scale testing (Phase 3)Study completedNCT01072929
What this trial is testing

Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Who this might be right for
Depression
Cephalon 433
Large-scale testing (Phase 3)Study completedNCT03187769
What this trial is testing

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Who this might be right for
SchizophreniaSchizophreniform DisordersBipolar I Disorder
Alkermes, Inc. 426
Post-approval studies (Phase 4)Study completedNCT00034580
What this trial is testing

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 326
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Large-scale testing (Phase 3)Study completedNCT00141271
What this trial is testing

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 536
Testing effectiveness (Phase 2)Ended earlyNCT00771134
What this trial is testing

Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression

Who this might be right for
Bipolar Disorder
H. Lundbeck A/S 105
Large-scale testing (Phase 3)Study completedNCT02046369
What this trial is testing

Lurasidone Pediatric Bipolar Study

Who this might be right for
Bipolar I Depression
Sumitomo Pharma America, Inc. 350
Large-scale testing (Phase 3)Study completedNCT04578756
What this trial is testing

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Who this might be right for
SchizophreniaBipolar I DisorderAutism Spectrum Disorder (ASD)
AbbVie 310
Large-scale testing (Phase 3)Study completedNCT00107731
What this trial is testing

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
AstraZeneca 710
Not applicableUnknownNCT01237158
What this trial is testing

Genetic Association Study Between GAD1 and Reelin Polymorphisms and GABA/Glutamate MRS in Bipolar Disorder Type 1 and Healthy Controls: SPECGENE PROJECT

Who this might be right for
Bipolar Disorder
University of Sao Paulo 140
Not applicableLooking for participantsNCT06221852
What this trial is testing

Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder

Who this might be right for
Bipolar I DisorderPsychosisSchizoaffective Disorder
Mclean Hospital 50
Large-scale testing (Phase 3)Study completedNCT00194116
What this trial is testing

Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression

Who this might be right for
Bipolar Disorder
University Hospitals Cleveland Medical Center 54
Large-scale testing (Phase 3)Looking for participantsNCT05303064
What this trial is testing

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Alkermes, Inc. 220
Large-scale testing (Phase 3)Ended earlyNCT01677182
What this trial is testing

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Who this might be right for
Bipolar Disorder
Takeda 535
Next Page